Observational studyBMC pediatrics2026
Early identification of infectious complications in pediatric burn patients: a prospective cohort study.
Observational study in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo assess early identification of infectious complications in pediatric burn patients and to evaluate the performance of the Intensive Care Infection Score (ICIS) in comparison with conventional inflammatory biomarkers.
designProspective observational cohort study.
settingTertiary pediatric burn intensive care unit. PATIENTS: Children admitted within 24 h of acute burn injury and requiring intensive care for ≥ 3 days.
interventionsNone. MEASUREMENTS AND MAIN
resultsSixty-nine children were enrolled; 18 (26%) experienced at least one infectious episode. Infection was defined using a composite reference standard that included clinical diagnosis, microbiological findings, and initiation of targeted antibiotic therapy. ICIS was calculated from extended complete blood count parameters obtained during routine clinical care. Receiver operating characteristic analysis demonstrated higher discriminative performance of ICIS compared with C-reactive protein and procalcitonin in this cohort. The area under the curve for ICIS was 0.93, compared with 0.71 and 0.72 for C-reactive protein and procalcitonin, respectively. At a cutoff value of ≥4, ICIS demonstrated very high sensitivity and negative predictive value in this cohort, with no false-negative observations, and a specificity of 0.70.
conclusionsIn pediatric burn patients, ICIS demonstrated high diagnostic accuracy in this cohort and improved discrimination compared with C-reactive protein and procalcitonin, particularly as a rule-out test. These findings provide novel evidence on the application of ICIS in a pediatric burn population. As ICIS is derived from routine blood counts without additional sampling or direct laboratory cost, it may represent a practical tool to support early clinical decision-making and antimicrobial stewardship in pediatric burn care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.